EUVIMEDEUVIMED entdecken
Crossref

Urothelial Carcinoma: Towards Integrated Biomarker Assessment

Christopher Poremba, Sabine Isabel Siegert

Trillium Pathology · 28.05.2026 · 4 (1) · 13

DOI: 10.47184/tp.2026.01.02 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trillium Pathology, online erschienen am 28.05.2026. Verfasst von Christopher Poremba und 1 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in molecular diagnostics have reshaped the understanding of urothelial carcinoma beyond conventional stage-based classification. Genomic alterations, immune-related biomarkers and molecular subtypes provide complementary insights into tumour biology and therapeutic response. Integrating these parameters into routine diagnostics supports more precise treatment selection and reflects a shift towards multi-dimensional, biomarker-driven oncology.

Zitieren

APA

Poremba, C., & Siegert, S. I. (2026). Urothelial Carcinoma: Towards Integrated Biomarker Assessment. Trillium Pathology, 4(1), 13. https://doi.org/10.47184/tp.2026.01.02

Vancouver

Poremba C, Siegert SI. Urothelial Carcinoma: Towards Integrated Biomarker Assessment. Trillium Pathology. 2026;4(1):13. doi:10.47184/tp.2026.01.02

BibTeX
@article{Poremba2026,
  author = {Poremba, Christopher and Siegert, Sabine Isabel},
  title = {Urothelial Carcinoma: Towards Integrated Biomarker Assessment},
  journal = {Trillium Pathology},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {13},
  doi = {10.47184/tp.2026.01.02}
}
Kostenlos starten →